Patent classifications
C08B31/02
ESTERIFIED STARCH AND STARCH-CONTAINING PLASTIC COMPOSITION
There is provided esterified starch which can be produced without using a non-aqueous organic solvent and has water resistance and miscibility with another plastic, and a starch-containing plastic composition. The esterified starch is obtained such that a starch mixture containing starch and a polyhydric alcohol, which is subjected to a heat treatment, is esterified with a vinyl ester and carbonate. Since the starch in the starch mixture enters a state in which starch granules are disintegrated by the polyhydric alcohol, by heating the starch mixture containing starch and a polyhydric alcohol, it is possible to esterify the starch without using a non-aqueous organic solvent and to obtain esterified starch having a high ester substitution degree. According to the esterified starch of the present invention, it is possible to obtain a starch-containing plastic composition having high hydrophobicity, and excellent water resistance and miscibility with another plastic.
ESTERIFIED STARCH AND STARCH-CONTAINING PLASTIC COMPOSITION
There is provided esterified starch which can be produced without using a non-aqueous organic solvent and has water resistance and miscibility with another plastic, and a starch-containing plastic composition. The esterified starch is obtained such that a starch mixture containing starch and a polyhydric alcohol, which is subjected to a heat treatment, is esterified with a vinyl ester and carbonate. Since the starch in the starch mixture enters a state in which starch granules are disintegrated by the polyhydric alcohol, by heating the starch mixture containing starch and a polyhydric alcohol, it is possible to esterify the starch without using a non-aqueous organic solvent and to obtain esterified starch having a high ester substitution degree. According to the esterified starch of the present invention, it is possible to obtain a starch-containing plastic composition having high hydrophobicity, and excellent water resistance and miscibility with another plastic.
PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES
A process for preparing a consumer product including a chemically modified polysaccharide, where the process includes the steps of combining a slurry including polysaccharide with a reactant to form a polysaccharide-reactant mixture, where the reactant includes an ester group; combining a base with the polysaccharide-reactant mixture to form a polysaccharide-reactant-base mixture; and allowing the polysaccharide-reactant-base mixture to form a transesterified polysaccharide mixture, where the transesterified polysaccharide mixture includes an alcohol.
Modified starch material of biocompatible hemostasis
A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
Modified starch material of biocompatible hemostasis
A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
Modified starch material of biocompatible hemostasis
A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
Modified starch material of biocompatible hemostasis
A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
Microspheres of hydrolysed starch with endogenous, charged ligands
Biodegradable microspheres having a diameter of 10-2000 m having cross-linked hydrolysed starch onto which at least one type of ligand has been coupled via a carboxylic ester bond. The ligand shall be an endogenous, charged molecule with a molecular mass of less than 1000 Da having at least one additional carboxylic acid function in addition to the one utilised for coupling the ligand to the microsphere and/or at least one amine function. On average 0.05-1.5 ligands are coupled to each glucose moiety in the hydrolysed starch.
Modified starch material of biocompatible hemostasis
A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
Modified starch material of biocompatible hemostasis
A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.